• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期肝细胞癌的治疗策略:射频消融联合与不联合经导管动脉化疗栓塞术与手术切除的比较。

Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.

机构信息

Department of Gastroenterological Surgery, Hiroshima University Hospital 1-2-3, Kasumi, Hiroshima, Japan.

出版信息

J Surg Oncol. 2011 Jul 1;104(1):3-9. doi: 10.1002/jso.21745.

DOI:10.1002/jso.21745
PMID:21656523
Abstract

BACKGROUND

The preferred choice between surgical treatment and radiofrequency ablation (RFA) for the treatment of small resectable hepatocellular [corrected] carcinoma (HCC) has become a subject for debate.

METHODS

We compared the results of hepatic resection (n = 199) with those of RFA (n = 87), of which 69 patients were treated with transcatheter arterial chemoembolization followed by RFA, for 286 patients with 3 or fewer nodules, none of which exceeded 3 cm in diameter at Hiroshima University Hospital.

RESULTS

In subgroup analysis of single HCC with tumor size exceeding 2 cm in Child-Pugh class A, the disease-free survival time was significantly longer in the surgical resection group than in the RFA group (P = 0.048). In the subgroups of a single and multiple HCC with tumor size ≤2 cm in Child-Pugh class A, the overall and disease-free survival rates were almost the same for the surgical resection and RFA groups (P = 0.46 and 0.58, respectively, in single HCC, and P = 0.98 and 0.98, respectively, in multiple HCC).

CONCLUSION

Surgical resection may provide better long-term disease-free survival than RFA in the subgroup of a single HCC exceeding 2 cm of Child-Pugh class A.

摘要

背景

对于治疗小的可切除肝细胞癌(HCC),手术治疗与射频消融(RFA)之间的首选方案一直存在争议。

方法

我们比较了肝切除术(n=199)和 RFA(n=87)的结果,其中 69 例患者接受了经导管动脉化疗栓塞(TACE)联合 RFA 治疗,这些患者在广岛大学医院均有 3 个或更少的结节,且每个结节的直径均不超过 3cm。

结果

在 Child-Pugh 分级为 A 的单个 HCC 且肿瘤直径超过 2cm 的亚组分析中,手术切除组的无疾病生存率明显长于 RFA 组(P=0.048)。在 Child-Pugh 分级为 A 的单个和多个 HCC 且肿瘤直径≤2cm 的亚组中,手术切除组和 RFA 组的总生存率和无疾病生存率几乎相同(在单个 HCC 中分别为 P=0.46 和 0.58,在多个 HCC 中分别为 P=0.98 和 0.98)。

结论

在 Child-Pugh 分级为 A 的单个 HCC 超过 2cm 的亚组中,手术切除可能比 RFA 提供更好的长期无疾病生存率。

相似文献

1
Treatment strategy for early hepatocellular carcinomas: comparison of radiofrequency ablation with or without transcatheter arterial chemoembolization and surgical resection.早期肝细胞癌的治疗策略:射频消融联合与不联合经导管动脉化疗栓塞术与手术切除的比较。
J Surg Oncol. 2011 Jul 1;104(1):3-9. doi: 10.1002/jso.21745.
2
Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.中等大小(3.1-5.0 厘米)肝细胞癌:经动脉化疗栓塞联合射频消融与单纯射频消融的比较。
Ann Surg Oncol. 2011 Jun;18(6):1624-9. doi: 10.1245/s10434-011-1673-8. Epub 2011 Mar 29.
3
Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.经导管动脉化疗栓塞联合射频消融治疗早期肝细胞癌:与手术切除的比较。
Cancer. 2010 Aug 1;116(15):3638-44. doi: 10.1002/cncr.25142.
4
Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.射频消融联合化疗栓塞术治疗肝切除术后复发性肝细胞癌。
AJR Am J Roentgenol. 2011 Aug;197(2):488-94. doi: 10.2214/AJR.10.4933.
5
Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.肝切除术或联合化疗栓塞及射频消融可提高肝细胞癌患者的生存率。
Digestion. 2007;75(2-3):104-12. doi: 10.1159/000104730. Epub 2007 Jun 26.
6
Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma.经导管动脉化疗栓塞联合射频消融治疗肝细胞癌。
Oncology. 2013;84 Suppl 1:40-3. doi: 10.1159/000345888. Epub 2013 Feb 20.
7
Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.原发性肝癌切除术后复发性肝癌患者的生存:治疗方式的比较效果。
Surgery. 2012 May;151(5):700-9. doi: 10.1016/j.surg.2011.12.015. Epub 2012 Jan 28.
8
[Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].经皮射频消融联合经动脉化疗栓塞及经皮乙醇注射治疗复发性小肝细胞癌
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Nov;26(11):1626-8.
9
[Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].[射频消融联合经动脉化疗栓塞治疗肝细胞癌肾上腺转移瘤切除术后局部复发性肿瘤——病例报告]
Gan To Kagaku Ryoho. 2009 Nov;36(12):2371-3.
10
Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.中大型肝细胞癌患者的中期结果:一项随机对照试验,旨在确定射频消融联合经导管动脉化疗栓塞的疗效。
Cancer. 2010 Dec 1;116(23):5452-60. doi: 10.1002/cncr.25314. Epub 2010 Jul 29.

引用本文的文献

1
Surgery or Percutaneous Ablation for Liver Tumors? The Key Points Are: When, Where, and How Large.肝肿瘤的手术治疗还是经皮消融治疗?关键在于:时机、部位和肿瘤大小。
Cancers (Basel). 2025 Apr 16;17(8):1344. doi: 10.3390/cancers17081344.
2
Benefits and drawbacks of radiofrequency ablation percutaneous or minimally invasive surgery for treating hepatocellular carcinoma.射频消融、经皮或微创手术治疗肝细胞癌的利弊
World J Gastrointest Surg. 2024 Nov 27;16(11):3400-3407. doi: 10.4240/wjgs.v16.i11.3400.
3
Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysis.
肝切除术与射频消融或经动脉化疗栓塞治疗早期(BCLC A)寡结节性肝细胞癌的比较:荟萃分析。
BJS Open. 2024 Jan 3;8(1). doi: 10.1093/bjsopen/zrad158.
4
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
5
Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis.经动脉化疗栓塞联合射频消融与肝切除术治疗肝细胞癌的Meta分析
Front Surg. 2022 Jul 11;9:948355. doi: 10.3389/fsurg.2022.948355. eCollection 2022.
6
Radiofrequency ablation vs. surgical resection for resectable hepatocellular carcinoma: A systematic review and meta-analysis.射频消融术与手术切除治疗可切除肝细胞癌的系统评价与Meta分析
Mol Clin Oncol. 2020 Jan;12(1):15-22. doi: 10.3892/mco.2019.1941. Epub 2019 Oct 31.
7
Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases.影像引导下高剂量率近距离放射治疗:一种联合介入放射学与放射肿瘤学技术在复杂病例中实现局部控制的初步结果及毒性反应
J Contemp Brachytherapy. 2015 Oct;7(5):327-35. doi: 10.5114/jcb.2015.54947. Epub 2015 Oct 13.
8
Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma.经导管动脉化疗栓塞联合CT引导下经皮热消融与肝切除术治疗肝细胞癌的对比研究
Chin J Cancer. 2015 Jun 10;34(6):254-63. doi: 10.1186/s40880-015-0023-9.
9
Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma.Meta 分析手术切除和射频消融治疗早期肝细胞癌。
World J Surg Oncol. 2012 Aug 16;10:163. doi: 10.1186/1477-7819-10-163.